L-Tyrosine, N-[(hexahydro-1H-azepin-1-yl)carbonyl]-L-leucyl-O-(phenylmethyl)-, 1,1-dimethylethyl ester manufacturers
- PD-151307
-
- $1980.00
-
2026-05-11
- CAS:225925-12-2
- Purity:
- Supply Ability: 10g
|
| | L-Tyrosine, N-[(hexahydro-1H-azepin-1-yl)carbonyl]-L-leucyl-O-(phenylmethyl)-, 1,1-dimethylethyl ester Basic information |
| | L-Tyrosine, N-[(hexahydro-1H-azepin-1-yl)carbonyl]-L-leucyl-O-(phenylmethyl)-, 1,1-dimethylethyl ester Chemical Properties |
| Boiling point | 752.6±60.0 °C(Predicted) | | density | 1+-.0.06 g/cm3(Predicted) | | pka | 13.92±0.20(Predicted) |
| | L-Tyrosine, N-[(hexahydro-1H-azepin-1-yl)carbonyl]-L-leucyl-O-(phenylmethyl)-, 1,1-dimethylethyl ester Usage And Synthesis |
| Uses | PD-151307 is an N-type calcium channel antagonist with significant inhibitory effects in IMR-32 human neuroblastoma cells, exhibiting an IC50 of 0.32 μM. PD-151307 can be used in research related to cancer therapy, anticonvulsants, and neuropathic pain[1]. | | References | [1] Hu LY, et al. N,N-dialkyl-dipeptidylamines as novel N-type calcium channel blockers. Bioorg Med Chem Lett. 1999 Mar 22;9(6):907-12. DOI:10.1016/s0960-894x(99)00100-6 |
| | L-Tyrosine, N-[(hexahydro-1H-azepin-1-yl)carbonyl]-L-leucyl-O-(phenylmethyl)-, 1,1-dimethylethyl ester Preparation Products And Raw materials |
|